SMART PHONE. SMARTER PHARMACY.

Put your pharmacy on your customers phone

Wednesday 11 Dec 2013 PHARMACYDAILY.COM.AU
SCAN SUBMIT PICK UP

GET STARTED TODAY

of those who have altered their medication have previously had a heart event 12% started taking natural remedies 9% completely stopped taking their medication since watching, reading or hearing about the show Heart Foundation national ceo Dr Lyn Roberts said the organisation has always had serious concerns about information presented in the Catalyst program and now there is strong data to confirm worst fears. The survey also showed that almost half of those who completely stopped their medications didnt consult their GP, Roberts said. What is most worrying is that of the people who have stopped taking their medication, one in four have previously had a heart event, such as a heart attack or stroke. This is extremely frightening as these are the people who are most at risk of having another heart attack or stroke, and they may not survive another one. Extrapolating the data means that we could see up to 2,000 or more heart attacks or strokes over the next 5 years, she warned. Roberts said the results reveal a major public health issue that governments cant ignore.

TGA adds new orphan

AMgEns blinatumomab has been granted orphan status by the Therapeutic Goods Administration (TGA) for a new indication as treatment for the rare disease named B-precursor acute lymphoblastic leukemia. Blinatumomab is available in powder form for reconstitution. CLICK HERE for TGAs orphan page.

Australians drop statins

A SIGNIFICANT number of people with high cholesterol have stopped or changed their cholesterol medication as a direct result of the recent ABC Catalyst programs (PD 30 Oct), a report released today by the National Heart Foundation of Australia has shown. Early fears of this possibility expressed by the National Heart Foundation and as criticised by ABCs own Media Watch program (PD 13 Nov) have been realised. Following the program, the National Heart Foundation surveyed 1,094 Australians who have been prescribed cholesterol medication by their health professional to understand the impact the TV program has had. The survey showed: 29% reported after watching the program they were initially confused, worried or scared that they were taking unnecessary medication 25% have seen their health care professional to discuss their medication since the program 22% changed their medication adherence, either by stopping, stopping then restarting or reducing the number of medications taken. One in four

GSK poppies for Vic

GlaXOSMithKlinE Australia has announced that their scientific trials growing poppies in Victoria is progressing positively. World demand for medicinal alkaloid (opiate) derived from poppies is high and at this stage commercial poppy production only takes place in Tasmania, under strict Tasmanian Government regulation. Tasmanian grown poppies supply nearly 50% of the worlds requirements.

IBS FODMAP support

A NEW food certification logo that indicates a given food is FODMAP Friendly (incorporating fructose and lactose-friendly foods) is destined to make life easier for IBS sufferers. The FODMAP Friendly certification was created to help people easily identify and select food products that are low in FODMAPs, which are a collection of short-chain carbohydrates and polyols that trigger symptoms of IBS and other inflammatory bowel diseases. The move has been initiated by dietitian Sue Shepherd, with selected items already featuring the logo and more to come shortly.

Sterile settlement

Your rst choice of digital medicines knowledge its simple

ThE US FDA has announced the $1.25m settlement of a civil action against J&J offshoot Advanced Sterilization Products (ASP), alleging that the firm manufactured and distributed adulterated and misbranded sterilization monitoring products. The FDA found the firm had insufficient data to support shelf life claims on certain products but continued to supply the items.

www.doseinnovations.com
Phone: 1800 003 673 or Email: enquiries@doseinnovations.com

Future proof your pharmacy now. Get Covad.

Call 1300 788 467 or visit us at www.covad.com.au
Pharmacy Daily Wednesday 11th December 2013 t 1300 799 220 w www.pharmacydaily.com.au page 1

Dont miss the Boat.

Follow us on:
Wednesday 11 Dec 2013 PHARMACYDAILY.COM.AU

Just one click away from keeping up to date with all the breaking news as it comes to hand...

Live, love, play, breathe

ChristMas may be a happy time for most in our society but for the two million plus Ausralians with asthma, its a time when dust and pollen can create more wheezing and sneezing than celebration. The National Asthma Council Australia is warning Australians with asthma to approach the festive season with caution, saying decorations, scented candles and even the humble Christmas tree can harbour hidden triggers. Most people are unaware that Cypress and pine trees produce high amounts of pollen, National Asthma Council Australia ceo Kristine Whorlow said. Artificial trees may seem like a safe alternative, but these trees are often used year after year and can accumulate dust and even mould in storage. A new Asthma Australia report on effects of uncontrolled asthma shows high absenteeism, career and negative daily living impacts, with 56% of patients with uncontrolled asthma taking asthma-related time off work. CLICK HERE to read the report or visit www.nationalasthma.org.au.

Chemo review report out

ThE Department of Health has published its report into the review of chemotherapy funding (PD 02 Dec), which recently resulted in more than $82m in additional PBS funding for the sector. The new funding arrangements will see pharmacies and hospitals receive $152.66 for every chemotherapy infusion they compound and dispense from 01 Jan 2014-30 Jun 2015. However after this 18 month period chemotherapy funding will be considered as part of any future agreement for pharmacy services under the PBS, the report says. Key findings of the review were that in the past excessive margins available from medicine price discounts had delivered substantial profits to chemotherapy providers. However now that the price disclosure measure has removed these high margins for multibrand medicines, remuneration available through PBS mark-ups and fees under Efficient Funding of Chemotherapy arrangements may no longer be sufficient to adequately meet the costs of compounding and supply for the average pharmacy. The review cited data provided by some pharmacies which showed that there may be a deficit in funding, however the small number of data sets and inconsistencies between reported costs mean its difficult to verify the overall impact of the changes. It also found that there is a high level of complexity in the sector, with various models some of which involve commercial or equity relationships between pharmacists, oncologists and hospitals. Beyond funding, efficiency benefits could be achieved by reducing the complexity and administrative burden associated with chemotherapy reimbursement on the PBS, the review concluded. CLICK HERE to view the report.

Mylan acquisition
alPhaPharM parent company Mylan has completed the acquisition of the Agila injectables business from Strides Arcolab, with the US$1.75 billion deal aiming to create a new global injectables platform for the company. Alphapharm says the deal significantly expands Mylans injectables business and also provides access to new geographic markets across the globe. Along with the takeover a number of other commercial enhancements have taken place which will reduce Agilas long-term reliance on a business to business model and increase its value. These changes unlock commercial rights and economics in many of Mylans key growth markets, including regaining full commercialisation rights for most of Agilas US portfolio and regaining significant product rights in Canada, Australia, Brazil, Japan and South Korea. According to Mylan president Rajiv Malik, the Agila deal transforms Mylan into a global powerhouse in injectables R&D and manufacturing, with four dedicated research & development facilities staffed by over 400 scientists, plus thirteen dedicated manufacturing sites in six countries. The transaction gives Mylan more than 1200 approved injectable products, along with 900 more pending global approvals across a broad range of therapeutic categories.

New PHARMAC drugs

NZs PHARMAC has agreed to fund Revolade (eltrombopag), a new drug for a rare and potentially fatal blood disorder, idiopathic thrombocytopenic purpura (ITP). PHARMAC estimates that about 40 patients will receive the product at a cost of $36,000 per patient per year starting 01 Jan 2014. And in other PHARMAC news, a new agreement with GSK sees the Special Authority criteria removed from Seretide, and anti-viral influenza treatment zanamavir (Relenza) plus Revolade will be listed while the price will reduce on all three currently listed asthma inhalers as a trade-off.

WIN A BIO-OIL MINI SPA PACK

Every day this week Pharmacy Daily is giving one lucky reader the chance to win a Bio-Oil Mini Spa Pack valued at $50. Despite being well known for its ability to help reduce the visible appearance of scars and stretch marks, Bio-Oil has a myriad of other skin-loving uses. Featuring a combination of plant oils (Calendula, Rosemary, Lavender and Chamomile) as well as Vitamins A and E, Bio-Oil helps promote healthy skin, smoothes and tones ageing skin and helps to combat dehydrated skin. Massage into the tops of the feet and the legs as part of a memorable at-home mini spa treatment. For more info go to http://www.bio-oil.com/en-us. For your chance to win this great prize pack, simply be the rst person to send in the correct answer to the question below.

MHRA Jext recall

ALK-Abell Ltd in the UK is recalling batches of Jext 300 and 150 micrograms solution for injection in pre-filled pens to patient level due to a potential problem with delivery of the dosage following activation of the auto injector. The UKs Medicines and Healthcare Products Regulatory Agency (MHRA) has issued an alert and is asking people who suffer severe allergic reactions and use a Jext adrenalin injector to check the batch numbers after the fault was discovered by the manufacturer. CLICK HERE for more details.

EMA nods Kogenate

ThE European Medicines Agencys Pharmacovigilance Risk Assessment Committee (PRAC) has reviewed the identical medicines Kogenate Bayer and Helixate NexGen and concluded that based on the full review of data available including the RODIN and EUHASS studies, the product is not associated with increased risk of developing factor VIII inhibitors compared with other products. For more details CLICK HERE.

What are the 4 botanical oils contained in Bio-Oil?

Email your answer to: comp@pharmacydaily.com.au Congratulations to yesterdays lucky winner, Natalie Lindner from Montville Pharmacy.

Pharmacy Daily Wednesday 11th December 2013 t 1300 799 220

w www.pharmacydaily.com.au

page 2

Advertise with us
For details call us today: 1300 799 220
Wednesday 11 Dec 2013 PHARMACYDAILY.COM.AU

Cost Effective Targeted Easy

P H A R M A C Y D A I L Y. C O M . A U

Health, Beauty and New Products

Welcome to our weekly feature with all the latest health, beauty and new products for pharmacy! Suppliers wanting to promote products in this feature should email newproducts@pharmacydaily.com.au

DISPENSARY CORNER
NOt the sort of dietary supplement youd expect. A worker in a US fast food restaurant has been fired after accidentally dropping a partiallysmoked marijuana cigarette into a customers cheeseburger. The incident allegedly took place at a Wendys drive-through eatery in the city of Atlanta, Georgia. The female customer purchased the burger and drove home with the food without realising what had happened until she took a bite from it and noticed a strange odour wafting from it, according to Sky News. When she took the top off the bun she saw the half-smoked joint inside and contacted the police. Officers arrested the 32-year-old employee who is alleged to have admitted to smoking at work. AnD while were on the subject of food, a team in the town of Bryan, Texas has set a new world record by building the biggest ever gingerbread house. Almost the size of a tennis court, the 7m high sweet edifice has earned a special certificate from Guinness World Records officials. It has a fully edible exterior built over a wooden frame, with the gingerbread including about a tonne of butter and brown sugar, more than 7,000 eggs, 3.2 tonnes of flower and 31kg of ginger. Icing and lollies were then added to decorate the amazing construction (below) which has so far survived weather extremes. One problem we did not anticipate was bees on warm days, said spokesman Bill Horton. They have been coming over, getting so much sugar and stumbling around like they are drunk, he said.

Get your skin feeling fabulously fragrant and fruity

Gentle enough to use every day without stripping your natural oils, Gaia Bodycare Body Wash is an ideal soap replacement to care for sensitive skin and leave it fresh and clean. The washes can be added to running bath water to create a revitalising bubble bath or relaxing soak, and are completely free from soap, sulphates & artificial scents. Available in two natural fragrances - Lavender & Frankincense or Pink Grapefruit & Jasmine. Stockist: Major wholesalers RRP: $12.95 for 250 ml Website: www.gaiaskinnaturals.com

Theyre definitely coming, whether you lice it or not

We all know how frustrating it is dealing with head lice and the unwanted impact treating head lice has on the familys daily routine. NeutraLice Advance Family Value Pack is clinically proven to kill head lice and eggs, and offers consumers great value for money. This is important when treating head lice on an ongoing basis, or when treating several people in the family. In addition the NeutraLice Advance Family Value Pack now includes a metal comb to make detecting and removing dead head lice and eggs easier and more efficient. If consumers arent satisfied with NeutraLice a money back offer is available on the NeutraLice Advance Lotion Kit, Natural Lotion Kit and Spray Lotion Kit - terms and conditions apply. Stockist: 1800 653 373 RRP: $32.95 Website: www.keypharm.com.au

The tooth, the whole tooth, and nothing but the tooth
You cant always protect yourself against accidently breaking or knocking out a tooth during play and sporting activities. SOS Dentobox is the only proven method to preserve broken and knocked out teeth. TGA approved, it can keep teeth viable for up to 48 hours. SOS Dentobox has an unrefrigerated shelf life of 3 years and is simple to use: recommended for all first aid kits anywhere where there are childrens playgrounds. Stockist: 0410 426 204 RRP: $59.95 Website: www.sosdentobox.com.au

Recover from those late nights with Recoverlyte

Recoverlyte, from the makers of Gastrolyte, is an Australian-first formulation which features a four-way blend of electrolytes, vitamins, minerals and amino acids to help the body recover efficiently from a big night out. Scientifically developed, Recoverlyte is a tropical flavoured effervescent powder designed to restore the bodys natural balance and provide a much needed energy boost when a late night involves lack of sleep, alcohol or vigorous activity, such as dancing. Stockist: 1800 732 273 RRP: $11.95 (pack of 10 sachets) Website: www.recoverlyte.com.au editors Bruce Piper and Mal Smith

email info@pharmacydaily.com.au advertising Magda Herdzik email advertising@pharmacydaily.com.au page 3

Pharmacy Daily is a publication for health professionals of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain written permission from the editor to reproduce any material. While every care has been taken in the preparation of Pharmacy Daily no liability can be accepted for errors or omissions. Information is published in good faith to stimulate independent investigation of the matters canvassed. Responsibility for editorial is taken by Bruce Piper.